Coronary artery disease - drug-eluting stents
Drug-eluting stents for the treatment of coronary artery disease (part review of NICE technology appraisal guidance 71) (TA152)
Chapter :
1. Guidance
NOTE: This guidance replaces sections 1.2–1.4 of NICE technology appraisal guidance 71 (2003).
Sections 1.1 and 1.5 of technology appraisal guidance 71 recommend when to use a stent. This part review recommends under what circumstances a drug eluting stent should be used.
1.1. Drug-eluting stents are recommended for use in percutaneous coronary intervention for the treatment of coronary artery disease, within their instructions for use, only if:
- the target artery to be treated has less than a 3-mm calibre or the lesion is longer than 15 mm, and
- the price difference between drug-eluting stents and bare-metal stents is no more than £300.
